MINIMED 670G

Device Medtronic, Inc.
Total Payments
$7.2M
Transactions
774
Doctors
31
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $97,688 56 3
2023 $2.0M 318 9
2022 $5.1M 400 28

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $7.2M 749 100.0%
Food and Beverage $813.37 24 0.0%
Travel and Lodging $40.00 1 0.0%

Payments by Type

Research
$7.2M
749 transactions
General
$853.37
25 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
CIP321 AHCL Pivotal Study Medtronic, Inc. $6.2M 7
CEP304 HCL Outcomes Study Medtronic, Inc. $961,111 7

Top Doctors Receiving Payments for MINIMED 670G — Page 2

Doctor Specialty Location Total Records
, D.O Obstetrics & Gynecology Southfield, MI $14.87 1
, M.D Endocrinology, Diabetes & Metabolism Asheville, NC $13.13 1
, M.D Endocrinology, Diabetes & Metabolism Asheville, NC $13.13 1
, MD Endocrinology, Diabetes & Metabolism Asheville, NC $13.13 1
, FNP Family Medicine Asheville, NC $13.13 1
, M.D Family Medicine Anderson, SC $12.32 1
, DNP, ARNP Nurse Practitioner Davenport, IA $5.64 1

About MINIMED 670G

MINIMED 670G is a device associated with $7.2M in payments to 31 healthcare providers, recorded across 774 transactions in the CMS Open Payments database. The primary manufacturer is Medtronic, Inc..

Payment data is available from 2022 to 2024. In 2024, $97,688 was paid across 56 transactions to 3 doctors.

The most common payment nature for MINIMED 670G is "Unspecified" ($7.2M, 100.0% of total).

MINIMED 670G is associated with 2 research studies, including "CIP321 AHCL Pivotal Study" ($6.2M).